Clinical considerations the use of inhaled corticosteroids for asthma

被引:15
作者
Williams, DM [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Div Pharmacotherapy, Chapel Hill, NC 27599 USA
来源
PHARMACOTHERAPY | 2001年 / 21卷 / 03期
关键词
D O I
10.1592/phco.21.4.38S.34260
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inhaled corticosteroids are the most potent and effective therapy for treating asthma. They exert their pharmacologic action through activation of the glucocorticoid receptor, which helps regulate gene transcription. Corticosteroids also directly inhibit several inflammatory mediators involved in the pathophysiology of asthma. In randomized, controlled clinical trials, inhaled corticosteroids. as monotherapy, are superior to other therapies in improving lung function and clinical outcomes in patients with asthma. However, the use of inhaled corticosteroids is limited by concerns of dose-related adverse effects, including growth suppression and decreased bone density Combination regimens with these agents and other long-term therapies are beneficial in maintaining asthma control while minimizing dose-related toxicities. Several inhaled corticosteroid products are available in the United States. They differ in potency; however, clinical efficacy is similar when equipotent doses are administered. A variety of factors influence product selection and patient response, including the therapeutic ratio, pharmacokinetic properties, and the inhalation delivery device. In addition, adherence to therapy and the patient's skill in administering the inhaled drug contribute to the therapeutic outcome.
引用
收藏
页码:38S / 48S
页数:11
相关论文
共 42 条
[1]  
Agertoft L, 1994, RESPIR MED, V5, P369
[2]   A METAANALYSIS OF THE EFFECT OF ORAL AND INHALED CORTICOSTEROIDS ON GROWTH [J].
ALLEN, DB ;
MULLEN, ML ;
MULLEN, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) :967-976
[3]   DRUG-THERAPY - INHALED GLUCOCORTICOIDS FOR ASTHMA [J].
BARNES, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :868-875
[4]   Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma [J].
Barnes, PJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (04) :S427-S433
[5]   ANTIINFLAMMATORY ACTIONS OF STEROIDS - MOLECULAR MECHANISMS [J].
BARNES, PJ ;
ADCOCK, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (12) :436-441
[6]   Efficacy and safety of inhaled corticosteroids - New developments [J].
Barnes, PJ ;
Pedersen, S ;
Busse, WW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :S1-S53
[7]   Psychological factors associated with medication nonadherence in asthmatic children [J].
Bender, B ;
Milgrom, H ;
Rand, C ;
Ackerson, L .
JOURNAL OF ASTHMA, 1998, 35 (04) :347-353
[8]   Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma [J].
Bleecker, ER ;
Welch, MJ ;
Weinstein, SF ;
Kalberg, C ;
Johnson, M ;
Edwards, L ;
Rickard, KA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) :1123-1129
[9]   Comparative assessment of safety and efficacy of inhaled corticosteroids: Report of a Committee of the Canadian Thoracic Society [J].
Boulet, LP ;
Cockcroft, DW ;
Toogood, J ;
Lacasse, Y ;
Baskerville, J ;
Hargreave, FE .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (05) :1194-1210
[10]  
Campbell LM, 1998, INT J CLIN PRACT, V52, P213